Factors influencing clinical trial participation for adult and pediatric patients with cystic fibrosis

被引:6
|
作者
Lee, Marissa [1 ]
Hu, Xun Yang [2 ]
Desai, Sameer [3 ]
Kwong, Eugenie [4 ]
Fu, Joey [4 ]
Flores, Eri [4 ]
Lazosky, Lynda [4 ]
Wilcox, Pearce G. [4 ,5 ,6 ]
Mcllwaine, Maggie [7 ]
Chilvers, Mark [7 ]
Yang, Connie [7 ]
Rayment, Jonathan H. [7 ]
Quon, Bradley S. [4 ,5 ,6 ]
机构
[1] Univ British Columbia, Fac Sci, Vancouver, BC V6T 1Z4, Canada
[2] Univ British Columbia, Fac Med, Vancouver, BC V6T 1Z4, Canada
[3] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z4, Canada
[4] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC V6T 1Z4, Canada
[5] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada
[6] Univ British Columbia, Vancouver, BC V6Z 1Y6, Canada
[7] Dept Pediat, Div Resp Med, Vancouver, BC V6H 3N1, Canada
关键词
Cystic fibrosis; Clinical trials; Research; Barriers; Facilitators;
D O I
10.1016/j.jcf.2020.08.019
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
There remains a limited understanding of the factors influencing clinical trial participation for individuals with Cystic Fibrosis (CF). A comprehensive survey was developed to examine the interests, preferences, and barriers/facilitators to research and clinical trial participation for CF patients. A consecutive sample of 198 CF adults attending the St. Paul's Hospital CF Clinic and parents of children with CF attending the BC Children's Hospital CF Clinic from Vancouver, Canada were surveyed. Parents of pediatric patients were less comfortable with blood collection, required more safety data prior to participating, and were more concerned about potential side effects. Very few respondents (<10%) appeared able/willing to fulfill the typical requirements to participate in a phase 1 clinical trial. Overall, there were more similarities than differences between the responses of adult and parents of pediatric CF patients. The patient-centered information can be used to inform the design of future clinical trials to enhance feasibility. (C) 2020 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [1] BARRIERS TO CLINICAL TRIAL PARTICIPATION IN THE ADULT CYSTIC FIBROSIS POPULATION
    Griffin, K.
    Rizvi, L.
    Tullis, E.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 362 - 362
  • [2] Factors Influencing Referral Of Pediatric Cystic Fibrosis Patients For Lung Transplantation Evaluation
    Wells, E.
    Schecter, M.
    Morales, D. L. S.
    Bryant, R.
    Towe, C.
    Johnson, J.
    Basu, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [3] FACTORS INFLUENCING REFERRAL OF PEDIATRIC CYSTIC FIBROSIS PATIENTS FOR LUNG TRANSPLANT EVLAUATION
    Wells, E.
    Schecter, M.
    Morales, D.
    Bryant, R.
    Towe, C.
    Johnson, J.
    Basu, A.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 371 - 371
  • [4] Factors influencing the need for endoscopic sinus surgery in adult patients with cystic fibrosis
    Brook, Christopher D.
    Maxfield, Alice Z.
    Ahmed, Hena
    Sedaghat, Ahmad R.
    Holbrook, Eric H.
    Gray, Stacey T.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2017, 31 (01) : 44 - 47
  • [5] Factors influencing clinical trial participation in breast cancer patients.
    Chagpar, A. B.
    Carron, K. R.
    McMasters, K. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S96 - S96
  • [6] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR CLINICAL OUTCOMES IN PEDIATRIC AND ADULT CYSTIC FIBROSIS PATIENTS
    Teibel, H.
    Burrus, T.
    Loy, S.
    Taylor, A.
    Sorgen, P.
    Pettit, R. S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S248 - S249
  • [7] Influenza B outbreak at an adult cystic fibrosis centre - Clinical impact and factors influencing spread
    Dennis, Jordan B.
    Jones, Andrew M.
    Davies, Emma A.
    Welfare, William
    Barry, Peter J.
    Collier, Lisa
    Turner, Andrew
    Bright-Thomas, Rowland J.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (05) : 808 - 814
  • [8] CLINICAL FACTORS ASSOCIATED WITH NEPHROTOXICITY IN PEDIATRIC CYSTIC FIBROSIS PATIENTS RECEIVING AMINOGLYCOSIDES
    Gardner, T. E.
    Pettit, R. S.
    Howenstine, M. S.
    Davis, S. D.
    Renbarger, J. L.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 346 - 347
  • [9] Factors influencing medical practitioner participation in population carrier screening for cystic fibrosis
    Valente, Giulia M.
    Amor, David J.
    Ioannou, Liane J.
    Archibald, Alison D.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 (02): : 232 - 238
  • [10] Evaluation of Home Medication Reconciliation by Clinical Pharmacists for Adult and Pediatric Cystic Fibrosis Patients
    Louie, Jessica M.
    Hong, Lisa T.
    Garavaglia, Lisa R.
    Pinal, Denise I.
    O'Brien, Catherine E.
    PHARMACY, 2018, 6 (03):